ImmuneBridge Raises $12M from M Ventures and Insight Partners to Advance Novel Natural Killer (NK) Cell-based Immunotherapies
Biotech company taps into human diversity for next-generation NK cell therapies ImmuneBridge, a biotechnology company using nature's innate intelligence to fight cancer, today announced the close of an oversubscribed $12 million seed financing co-led …